Clinical Trial Update: Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing palliation of dyspnea with morphine in patients with interstitial lung disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea
• Interstitial Lung Disease

Drugs mentioned

• Morphine (morphine)

Snippet

Sponsor: University of Aarhus | Conditions: Interstitial Lung Disease, Dyspnea | Phase 4 | Status: COMPLETED